Matches in SemOpenAlex for { <https://semopenalex.org/work/W293642904> ?p ?o ?g. }
- W293642904 endingPage "4664" @default.
- W293642904 startingPage "4648" @default.
- W293642904 abstract "The orexin/hypocretin receptors are a family of G protein-coupled receptors and consist of orexin-1 (OX1) and orexin-2 (OX2) receptor subtypes. Orexin receptors are expressed throughout the central nervous system and are involved in the regulation of the sleep/wake cycle. Because modulation of these receptors constitutes a promising target for novel treatments of disorders associated with the control of sleep and wakefulness, such as insomnia, the development of orexin receptor antagonists has emerged as an important focus in drug discovery research. Here, we report the design, synthesis, characterization, and structure-activity relationships (SARs) of novel orexin receptor antagonists. Various modifications made to the core structure of a previously developed compound (-)-5, the lead molecule, resulted in compounds with improved chemical and pharmacological profiles. The investigation afforded a potential therapeutic agent, (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006), an orally active, potent orexin antagonist. The efficacy was demonstrated in mice in an in vivo study by using sleep parameter measurements." @default.
- W293642904 created "2016-06-24" @default.
- W293642904 creator A5012874068 @default.
- W293642904 creator A5024733702 @default.
- W293642904 creator A5034213618 @default.
- W293642904 creator A5036472505 @default.
- W293642904 creator A5044760409 @default.
- W293642904 creator A5047152848 @default.
- W293642904 creator A5050768229 @default.
- W293642904 creator A5054434986 @default.
- W293642904 creator A5065322892 @default.
- W293642904 creator A5082001516 @default.
- W293642904 creator A5087796283 @default.
- W293642904 creator A5088299573 @default.
- W293642904 creator A5016382489 @default.
- W293642904 date "2015-05-22" @default.
- W293642904 modified "2023-09-30" @default.
- W293642904 title "Discovery of (1<i>R</i>,2<i>S</i>)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-<i>N</i>-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist" @default.
- W293642904 cites W1519232679 @default.
- W293642904 cites W1959892192 @default.
- W293642904 cites W1973662703 @default.
- W293642904 cites W1977320288 @default.
- W293642904 cites W1983298714 @default.
- W293642904 cites W1987647554 @default.
- W293642904 cites W1992009093 @default.
- W293642904 cites W2016329740 @default.
- W293642904 cites W2018441208 @default.
- W293642904 cites W2020744386 @default.
- W293642904 cites W2027740042 @default.
- W293642904 cites W2028353633 @default.
- W293642904 cites W2031915584 @default.
- W293642904 cites W2033473705 @default.
- W293642904 cites W2033581027 @default.
- W293642904 cites W2035018594 @default.
- W293642904 cites W2038506486 @default.
- W293642904 cites W2040910584 @default.
- W293642904 cites W2050003210 @default.
- W293642904 cites W2051712994 @default.
- W293642904 cites W2068060863 @default.
- W293642904 cites W2068471533 @default.
- W293642904 cites W2072154498 @default.
- W293642904 cites W2074379521 @default.
- W293642904 cites W2080548859 @default.
- W293642904 cites W2081175581 @default.
- W293642904 cites W2101362443 @default.
- W293642904 cites W2102943634 @default.
- W293642904 cites W2111203770 @default.
- W293642904 cites W2111723991 @default.
- W293642904 cites W2113198227 @default.
- W293642904 cites W2121564252 @default.
- W293642904 cites W2129357751 @default.
- W293642904 cites W2131263310 @default.
- W293642904 cites W2140599926 @default.
- W293642904 cites W2141154265 @default.
- W293642904 cites W2141240449 @default.
- W293642904 cites W2152211310 @default.
- W293642904 cites W2159953069 @default.
- W293642904 cites W49933285 @default.
- W293642904 cites W66525018 @default.
- W293642904 doi "https://doi.org/10.1021/acs.jmedchem.5b00217" @default.
- W293642904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25953512" @default.
- W293642904 hasPublicationYear "2015" @default.
- W293642904 type Work @default.
- W293642904 sameAs 293642904 @default.
- W293642904 citedByCount "65" @default.
- W293642904 countsByYear W2936429042015 @default.
- W293642904 countsByYear W2936429042016 @default.
- W293642904 countsByYear W2936429042017 @default.
- W293642904 countsByYear W2936429042018 @default.
- W293642904 countsByYear W2936429042019 @default.
- W293642904 countsByYear W2936429042020 @default.
- W293642904 countsByYear W2936429042021 @default.
- W293642904 countsByYear W2936429042022 @default.
- W293642904 countsByYear W2936429042023 @default.
- W293642904 crossrefType "journal-article" @default.
- W293642904 hasAuthorship W293642904A5012874068 @default.
- W293642904 hasAuthorship W293642904A5016382489 @default.
- W293642904 hasAuthorship W293642904A5024733702 @default.
- W293642904 hasAuthorship W293642904A5034213618 @default.
- W293642904 hasAuthorship W293642904A5036472505 @default.
- W293642904 hasAuthorship W293642904A5044760409 @default.
- W293642904 hasAuthorship W293642904A5047152848 @default.
- W293642904 hasAuthorship W293642904A5050768229 @default.
- W293642904 hasAuthorship W293642904A5054434986 @default.
- W293642904 hasAuthorship W293642904A5065322892 @default.
- W293642904 hasAuthorship W293642904A5082001516 @default.
- W293642904 hasAuthorship W293642904A5087796283 @default.
- W293642904 hasAuthorship W293642904A5088299573 @default.
- W293642904 hasConcept C118303440 @default.
- W293642904 hasConcept C135285700 @default.
- W293642904 hasConcept C150903083 @default.
- W293642904 hasConcept C15744967 @default.
- W293642904 hasConcept C169760540 @default.
- W293642904 hasConcept C170493617 @default.
- W293642904 hasConcept C185592680 @default.
- W293642904 hasConcept C207001950 @default.
- W293642904 hasConcept C2776119998 @default.
- W293642904 hasConcept C2776885963 @default.